Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05017012 |
| Title | A Study to Evaluate the Bioavailability of Pembrolizumab (MK-3475) Via Subcutaneous (SC) Injection of MK-3475A (Pembrolizumab Formulated With MK-5180) In Advanced Solid Tumors (MK-3475A-C18) |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Merck Sharp & Dohme Corp. |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | HUN | ESP |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| FALP-UIDO ( Site 0101) | Santiago | Region M. de Santiago | 7500921 | Chile | Details | |
| Bradfordhill ( Site 0100) | Santiago | Region M. de Santiago | 8420383 | Chile | Details | |
| James Lind Centro de Investigación del Cáncer ( Site 0102) | Temuco | Región de la Araucanía | 4800827 | Chile | Details | |
| Országos Onkológiai Intézet-Urogenital Tumors Department and Clinical Pharmacology ( Site 0021) | Budapest | Pest County | 1122 | Hungary | Details | |
| Magyar Honvedseg Egeszsegugyi Kozpont-Onkologiai Osztaly ( Site 0020) | Budapest | 1062 | Hungary | Details | ||
| Kansai Medical University Hospital ( Site 0112) | Hirakata | Osaka | 573-1191 | Japan | Details | |
| Saitama Prefectural Cancer Center ( Site 0110) | Ina-machi | Saitama | 362-0806 | Japan | Details | |
| Shizuoka Cancer Center ( Site 0111) | Nagaizumi-cho,Sunto-gun | Shizuoka | 411-8777 | Japan | Details | |
| National Hospital Organization Kyushu Cancer Center ( Site 0114) | Fukuoka | 811-1395 | Japan | Details | ||
| Osaka International Cancer Institute ( Site 0113) | Osaka | 541-8567 | Japan | Details | ||
| CANCERCARE LANGENHOVEN DRIVE ONCOLOGY CENTRE ( Site 0051) | Port Elizabeth | Eastern Cape | 6055 | South Africa | Details | |
| Medical Oncology Centre of Rosebank ( Site 0058) | Johannesburg | Gauteng | 2196 | South Africa | Details | |
| Steve Biko Academic Hospital-Medical Oncology ( Site 0057) | Pretoria | Gauteng | 0001 | South Africa | Details | |
| LIFE GROENKLOOF-Mary Potter Cancer Centre ( Site 0052) | Pretoria | Gauteng | 0181 | South Africa | Details | |
| Sandton Oncology Medical Group (Pty) Ltd-Research ( Site 0053) | Sandton | Gauteng | 2196 | South Africa | Details | |
| Cape Town Oncology Trials ( Site 0050) | Cape Town | Western Cape | 7570 | South Africa | Details | |
| Cancercare Rondebosch Oncology-Clinical trials ( Site 0055) | Rondebosch | Western Cape | 7700 | South Africa | Details | |
| Severance Hospital, Yonsei University Health System ( Site 0062) | Seoul | 03722 | South Korea | Details | ||
| Samsung Medical Center ( Site 0063) | Seoul | 06351 | South Korea | Details | ||
| Hospital Universitario Virgen de la Victoria-Phase I Trials Unit ( Site 0042) | Málaga | Andalusia | 29010 | Spain | Details | |
| HOSPITAL CLÍNIC DE BARCELONA-Department of Medical Oncology ( Site 0043) | Barcelona | Catalonia | 08036 | Spain | Details | |
| HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑON-ONCOLOGY ( Site 0040) | Madrid | Madrid, Comunidad de | 28009 | Spain | Details |